Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
head and neck cancer
Biotech
Nykode bets future on cancer trial after losing Genentech pact
While the axing of the Genentech deal was the initial blow, Nykode is also contending with the potential loss of future revenues from Regeneron.
Nick Paul Taylor
Aug 27, 2025 8:25am
PDS reports 39 months OS in phase 2 head and neck cancer trial
Aug 25, 2025 9:00am
Bicara CEO: ASCO data resonate more with 'people that matter'
Jun 2, 2025 4:26pm
ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data
Jun 1, 2025 3:36pm
Merus hails 'unprecedented' survival on solid tumor bispecific
May 23, 2025 7:35am
Immutep's LAG-3 agent posts 'impressive' survival data
May 5, 2025 10:37am
